Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Chad Cowan currently holds 1,175,680 shares of Century Therapeutics, Inc. (IPSC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chad Cowan has been a net buyer of IPSC stock. They have purchased $49.4K and sold $2.7K worth of shares.
Chad Cowan's most recent insider trade was on Apr 1, 2026, when they sold 1,365 shares at $2.19 per share.
Chad Cowan serves as Executive at Century Therapeutics, Inc. (IPSC). They have executed 5 insider transactions totaling $52.1K over their tenure at the company.
Chad Cowan holds the position of Executive at Century Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Chad Cowan has shown a buying trading pattern, with $49.4K in total purchases and $2.7K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Chad Cowan was on Dec 22, 2025, when they purchased $49.4K worth of IPSC shares. This transaction involved 58,060 shares at $0.85 per share.
Chad Cowan currently owns 1,175,680 shares of Century Therapeutics, Inc. (IPSC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Chad Cowan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Chad Cowan has 5 Form 4 filings on record as an insider at Century Therapeutics, Inc..
Set alerts for Chad Cowan and 40,000+ other insiders.